Andrew Hanna

Title: The Innovative Contributions of Andrew Hanna

Introduction

Andrew Hanna is a notable inventor based in Lutz, Florida, recognized for his significant contributions to cancer treatment through innovative pharmaceutical compositions. With a total of two patents, Hanna has focused on developing novel crystalline forms of existing cancer treatments, enhancing their efficacy and delivery.

Latest Patents

Hanna's latest patents include "Crystalline forms of Actinomycin D for treatment of cancer," which details the synthesis and characterization of novel DACT forms suitable for pharmaceutical compositions in drug delivery systems. These forms are designed to treat cancer in humans and warm-blooded mammals. The novel forms encompass cocrystals, salts, solvates of salts, and mixtures thereof. Another significant patent is "Crystalline forms of mitomycin C for treatment of cancer," which also focuses on the synthesis and characterization of new crystalline forms of mitomycin C, aimed at improving drug delivery systems for treating human and warm-blooded diseases.

Career Highlights

Hanna is currently associated with Transgenex Nanobiotech Inc., where he continues to push the boundaries of pharmaceutical innovation. His work is pivotal in the ongoing fight against cancer, as he seeks to improve the effectiveness of existing treatments through novel formulations.

Collaborations

Hanna collaborates with talented individuals such as Mazen Hanna and Manomi Perera, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Andrew Hanna's work exemplifies the spirit of innovation in the pharmaceutical industry, particularly in the realm of cancer treatment. His patents reflect a commitment to improving drug delivery systems, ultimately benefiting patients in need.